Greenland Mines Ltd is the next-generation explorer unlocking the Skaergaard Intrusion – an iconic, strata-bound PGM-Au-Cu deposit in Southeast Greenland emplaced 56 million years ago during the continental break-up and the opening of the North Atlantic Ocean.
Acquired in 2020 (formerly Major Precious Metals Corp.), $30 Million has been invested since the 1990s into de-risking the Skaergaard Project, culminating in a 2022 NI 43-101 upgrade: 95% Indicated resource growth, 28% total contained metal increase, an Indicated (11.4 Moz PdEq) and Inferred (14.5 Moz PdEq) Mineral Resource comprising gold, palladium, and platinum.
We’re not just drilling – we’re building a legacy. With 3 MELs spanning 877 km², full permits, and onsite logistics (Sødalen airstrip, heli-access), the Skaergaard Project is shovel-ready for expansion. Through a new drilling and development program, Greenland Mines aims to double its resource to ~50 million contained ounces of Au, Pd, and Pt, as well as adding vanadium and gallium to its raw critical metals portfolio.
Greenland Mines Ltd is led by an experienced team of mining, geological, and capital markets professionals with deep expertise in Arctic resource development, Greenlandic regulatory navigation, and international investor relations.
Skaergaard Intrusion in East Greenland was emplaced around 56 million years ago beneath an accumulating series of plateau basalts that had formed during the continental break-up and the opening of the North Atlantic Ocean.
First major scientific expedition to Skaergaard was led by L. R. Wagner during 1935/36, resulting in a monumental memoir (Wagner and Deer 1939), arguably one of the most significant petrological publications of the 20th century.
1986 saw the discovery of a giant, strata-bound gold and palladium deposit of a previously unknown type, forming distinct and repeated Platinum Group Metals (PGM), gold and copper enriched levels that resemble a 50 metre stack of layer-concordant gold-rimmed saucers defined by palladium and platinum rich gabbro known as the “Triple Group” due to its three prominent layers.
Due to its iconic status, the Skaergaard Intrusion has been the subject of research and study at various institutions, particularly those with strong geology or earth science programs.
Skaergaard Intrusion discovered
L.R. Wagner’s landmark expedition
Platinova discovers “Triple Group”
Three layers of Pd-Pt-Au in grabbo
Platina drills 35,000 metres
Scoping study hints at PFS
Major Precious Metals
Adds MEL 2021-10 for northern upside
NI 43-101 MRE
+95% Indicated; +28% contained metal
Greenland Mines
Corp restructuring and exploration plan
U.S. listing on Nasdaq
New financing for expansion
Founder, Chief Executive Officer (CEO), Director and Chairman of the Board
Dr. Sinkule is the company’s Chief Executive Officer (CEO), Founder, and the Chairman of the Board of Directors. He has over 40 years of drug, biologic, and medical device R&D and commercialization experience. This serial entrepreneur is the founder and driving force behind the Company, its growing product portfolio, and its financing strategies. He has personally managed over 8 drug and biotech products successfully through FDA approval to market, 5 medical devices and 8 in vitro diagnostics. He has hired and managed both small and large teams of experienced people in pharma and biotech organizations, and managed contract research organizations (“CROs”) and contract development and manufacturing companies (“CDMOs”), working for large and small clients. After serving in academics and then in industry, Dr. Sinkule has evolved into a successful businessman and entrepreneur. He serves on the Board of two companies, and routinely consults for venture capitalist firms, investment banks, as well as both large and early-stage pharmaceutical and biotech companies.
Chief Financial Officer
Jeffrey has over 20 years of experience in managing financial operations, investing, advising Fortune 500 companies, and launching new ventures. He is the co-founder of Winvest Acquisition Corp. (Ticker: WINV), a special purpose acquisition company. Prior to Winvest, Jeffrey launched Out of Print, a direct-to-consumer merchandise platform that was acquired by Penguin Random House in 2017. He previously served in investment roles at Greenlight Capital and GE Capital, and started his career at McKinsey and Co. Jeffrey previously served on the Boards of Riot New Media Group and Books For Africa. He received an MBA from Harvard Business School and a BS in Chemical Engineering from MIT.
President
Bo is a seasoned executive with over 20 years in mineral exploration and natural resource development across Europe and the Arctic, starting in Greenland geology in 1998. Holding a PhD in economic geology and former Senior Research Scientist at the Geological Survey of Danmark and Greenland, he has led listed and private resource companies, advancing projects from early exploration to exploitation through technical studies, environmental/social impact assessments, permitting, and stakeholder engagement. His expertise includes listed-company leadership, international investor relations, building expert teams, and leveraging extensive networks in business, academia, politics, and the European raw materials ecosystem – gained partly from his senior advisory role at EIT RawMaterials advising on EU policy and funding. This positions him as a strong leader for Greenland Mines Corp, providing credible access to North American and European capital markets and strategic partners.
Vice President, Exploration
Dr. Delendatti is a geologist with more than 25 years of global exploration experience, spanning a wide variety of mineral deposit types. He previously served as Exploration Manager at Sayona Mining, where he played a critical role in advancing the Authier Lithium Project through pre-definitive feasibility stage, tripling the resource in the process. His earlier roles at Elementos and Exeter Resource, including managing the world-class Caspiche copper-gold project in Chile, highlight his ability to deliver growth in complex geological settings. At Skaergaard, he leads the technical work underpinning resource expansion and development.
Country Manager Logistics & Studies
Hans is a seasoned senior executive with over 30 years of hands-on experience living and working in Greenland, specializing in operational, logistical, and facility management for mineral exploration, resource development, and Arctic mining projects. Deeply connected across the country, he has built and led on-the-ground companies, planned and executed large-scale field campaigns, managed complex logistics, established remote camps and infrastructure, and coordinated key technical studies—including environmental, social, and feasibility assessments—while engaging stakeholders, handling CSR, public hearings, and working closely with authorities and consultants. His practical expertise in Arctic logistics, study coordination, and regulatory navigation directly addresses major execution challenges in Greenland mining, making him invaluable for effective incountry project delivery.
Permitting & Community Manager
Robert is a highly experienced Greenlandic executive based in Nuuk, with deep local roots, fluent language skills, and extensive networks across Greenland’s business, political, and community spheres. His career includes leadership in logistics, entrepreneurship, fisheries, specialized mining consultancy, and stakeholder relations for resource projects, with a strong focus on government liaison, regulatory engagement, health & safety, and aligning initiatives with Greenlandic societal expectations. Renowned for his cultural insight, permitting expertise, and ability to build trust at all levels, Robert plays a pivotal role in securing and maintaining the project’s social licence to operate, minimizing social and political risks, and navigating Greenland’s regulatory landscape to balance community interests with efficient project advancement and partnerships.
In addition to its natural resources activities, Greenland Mines Ltd has a division dedicated to realizing the potential of biologic, cell and gene therapies to offer transformative patient outcomes in areas of high unmet medical need by extending the reach of protein, cell, and gene therapies to highly prevalent neurodegenerative disorders like Alzheimer’s, amyotrophic lateral sclerosis (ALS), Parkinson’s, and other age-related disorders.
Our vision is to build a leading gene therapy company for the treatment of neurodegenerative diseases by progressing our patented á-Klotho gene therapy research programs and identifying, developing, and commercializing other novel gene therapy treatments and in vitro diagnostics for neurodegenerative diseases, and other age-related pathologies.
We have assembled a portfolio of gene therapy candidates in partnership with leading scientific institutions and have built a team with extensive experience in the biotechnology commercialization and gene therapy space. Our team will pursue new innovations in vector design and delivery to optimize our investigational gene therapy products for safety, potency, durability, and clinical response. We plan on building integrated internal development capabilities from product development through commercialization and focus on accelerating the pace of product development in the clinic. In addition, as part of our ongoing business strategy, we continue to explore potential opportunities to acquire or license new product candidates as well as opportunities for partnership or collaboration on our existing products in development.